Siegfried Muhlack

1.2k total citations
46 papers, 981 citations indexed

About

Siegfried Muhlack is a scholar working on Neurology, Cellular and Molecular Neuroscience and Rheumatology. According to data from OpenAlex, Siegfried Muhlack has authored 46 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 8 papers in Rheumatology. Recurrent topics in Siegfried Muhlack's work include Parkinson's Disease Mechanisms and Treatments (37 papers), Neurological disorders and treatments (22 papers) and Folate and B Vitamins Research (8 papers). Siegfried Muhlack is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (37 papers), Neurological disorders and treatments (22 papers) and Folate and B Vitamins Research (8 papers). Siegfried Muhlack collaborates with scholars based in Germany, United States and Switzerland. Siegfried Muhlack's co-authors include Thomas Müller, Dirk Woitalla, C. Coronado Erdmann, Dirk Bremen, H. Przuntek, Ralf Gold, Lars Tönges, Oliver Goetze, Thomas Müller and Wolfgang E. Schmidt and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Neurology Neurosurgery & Psychiatry and Movement Disorders.

In The Last Decade

Siegfried Muhlack

46 papers receiving 968 citations

Peers

Siegfried Muhlack
Isabel Wurster Germany
Marianna Selikhova United Kingdom
Peter Valkovič Slovakia
Francesca Magrinelli Italy
Nil Dizdar Sweden
Fang Ba Canada
Ilona Csóti Germany
Mun Kyung Sunwoo South Korea
Matthias Löhle Germany
O. Rascol France
Isabel Wurster Germany
Siegfried Muhlack
Citations per year, relative to Siegfried Muhlack Siegfried Muhlack (= 1×) peers Isabel Wurster

Countries citing papers authored by Siegfried Muhlack

Since Specialization
Citations

This map shows the geographic impact of Siegfried Muhlack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siegfried Muhlack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siegfried Muhlack more than expected).

Fields of papers citing papers by Siegfried Muhlack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siegfried Muhlack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siegfried Muhlack. The network helps show where Siegfried Muhlack may publish in the future.

Co-authorship network of co-authors of Siegfried Muhlack

This figure shows the co-authorship network connecting the top 25 collaborators of Siegfried Muhlack. A scholar is included among the top collaborators of Siegfried Muhlack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siegfried Muhlack. Siegfried Muhlack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartig, Dirk, Daniel Richter, Siegfried Muhlack, et al.. (2022). COVID-19 outcomes in hospitalized Parkinson’s disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany. SHILAP Revista de lepidopterología. 4(1). 27–27. 1 indexed citations
2.
Gold, Ralf, et al.. (2020). Parkinson’s Disease Multimodal Complex Treatment (PD-MCT): Analysis of Therapeutic Effects and Predictors for Improvement. Journal of Clinical Medicine. 9(6). 1874–1874. 17 indexed citations
3.
Maass, Fabian, et al.. (2019). Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease. Cells. 8(2). 105–105. 31 indexed citations
4.
5.
Pesch, Beate, Swaantje Casjens, Dirk Woitalla, et al.. (2019). Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson’s Disease. Cells. 8(2). 96–96. 28 indexed citations
6.
Tönges, Lars, Dirk Bartig, Siegfried Muhlack, et al.. (2019). Charakteristika und Dynamik der stationären Behandlung von Parkinson-Patienten in Deutschland: Analyse von 1,5 Mio. Patientenfällen aus den Jahren 2010 bis 2015. Der Nervenarzt. 90(2). 167–174. 1 indexed citations
7.
Casjens, Swaantje, Shalmali Dharmadhikari, Anne Lotz, et al.. (2018). Association of exposure to manganese and iron with striatal and thalamic GABA and other neurometabolites - Neuroimaging results from the WELDOX II study. PMC. 2 indexed citations
8.
Muhlack, Siegfried, et al.. (2018). Emerging Immunotherapies for Parkinson Disease. Neurology and Therapy. 8(1). 29–44. 46 indexed citations
9.
Richter, Daniel, Dirk Woitalla, Siegfried Muhlack, et al.. (2018). Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients. Frontiers in Neurology. 9. 645–645. 16 indexed citations
10.
Pesch, Beate, Ulrike Dydak, Anne Lotz, et al.. (2017). Association of exposure to manganese and iron with relaxation rates R1 and R2*- magnetic resonance imaging results from the WELDOX II study. NeuroToxicology. 64. 68–77. 14 indexed citations
11.
Müller, Thomas, et al.. (2016). Levodopa increases oxidative stress and repulsive guidance molecule A levels: a pilot study in patients with Parkinson’s disease. Journal of Neural Transmission. 123(4). 401–406. 33 indexed citations
12.
Müller, Thomas & Siegfried Muhlack. (2014). Levodopa-related cysteinyl–glycine and cysteine reduction with and without catechol-O-methyltransferase inhibition in Parkinson’s disease patients. Journal of Neural Transmission. 121(6). 643–648. 13 indexed citations
13.
Müller, Thomas, et al.. (2011). Levodopa Induces Synthesis of Nerve Growth Factor and Growth Hormone in Patients With Parkinson Disease. Clinical Neuropharmacology. 34(3). 101–103. 5 indexed citations
14.
Müller, Thomas & Siegfried Muhlack. (2011). Cysteinyl‐glycine reduction as marker for levodopa‐induced oxidative stress in Parkinson's disease patients. Movement Disorders. 26(3). 543–546. 28 indexed citations
15.
Müller, Thomas, et al.. (2008). Catechol-O-methyltransferase Inhibition Improves Levodopa-Associated Strength Increase in Patients With Parkinson Disease. Clinical Neuropharmacology. 31(3). 134–140. 10 indexed citations
16.
Müller, Thomas & Siegfried Muhlack. (2008). Impact of endurance exercise on levodopa-associated cortisol release and force increase in patients with Parkinson’s disease. Journal of Neural Transmission. 115(6). 851–855. 8 indexed citations
17.
Müller, Thomas, et al.. (2006). Acute levodopa administration reduces cortisol release in patients with Parkinson’s disease. Journal of Neural Transmission. 114(3). 347–350. 22 indexed citations
18.
Müller, Thomas, C. Coronado Erdmann, Siegfried Muhlack, et al.. (2006). Entacapone improves complex movement performance in patients with Parkinson’s disease. Journal of Clinical Neuroscience. 14(5). 424–428. 11 indexed citations
19.
Muhlack, Siegfried, et al.. (2004). Simple movement sequences better correlate to levodopa plasma levels than complex ones. Journal of neural transmission. Supplementum. 53–60. 3 indexed citations
20.
Uekermann, J., Irene Daum, Siegfried Muhlack, et al.. (2004). Differential executive control impairments in early Parkinson’s disease. Journal of neural transmission. Supplementum. 39–51. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabel Wurster Breakdown of academic impact, for papers by Marianna Selikhova Breakdown of academic impact, for papers by Peter Valkovič Breakdown of academic impact, for papers by Francesca Magrinelli Breakdown of academic impact, for papers by Nil Dizdar Breakdown of academic impact, for papers by Fang Ba Breakdown of academic impact, for papers by Ilona Csóti Breakdown of academic impact, for papers by Mun Kyung Sunwoo Breakdown of academic impact, for papers by Matthias Löhle Breakdown of academic impact, for papers by O. Rascol
Rankless by CCL
2026